Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

872 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretransplant increasing rate of lactate dehydrogenase as a predictor of transplant outcomes for patients with myeloid hematological malignancies.
Morishita T, Matsumoto R, Naito T, Domon Y, Takeda K, Ishigiwa K, Ichiki T, Okabe M, Eguchi M, Kawaguchi Y, Ohbiki M, Goto T, Ozawa Y, Miyamura K. Morishita T, et al. Bone Marrow Transplant. 2021 Jul;56(7):1732-1736. doi: 10.1038/s41409-021-01241-w. Epub 2021 Mar 8. Bone Marrow Transplant. 2021. PMID: 33686247 No abstract available.
Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.
Sato T, Seto A, Kagaya Y, Kawashima N, Koyama D, Morishita T, Ozawa Y, Miyamura K, Yamaguchi T, Haruta JI, Ito M. Sato T, et al. Among authors: morishita t. Bone Marrow Transplant. 2018 Oct;53(10):1359-1363. doi: 10.1038/s41409-018-0197-2. Epub 2018 May 8. Bone Marrow Transplant. 2018. PMID: 29740179 Clinical Trial. No abstract available.
Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage Complications.
Morishita T, Okabe M, Kawaguchi Y, Lee Y, Ohbiki M, Osaki M, Goto M, Araie H, Sato T, Goto T, Ozawa Y, Miyamura K. Morishita T, et al. Biol Blood Marrow Transplant. 2018 Dec;24(12):2509-2516. doi: 10.1016/j.bbmt.2018.07.029. Epub 2018 Jul 25. Biol Blood Marrow Transplant. 2018. PMID: 30053646 Free article.
[Leukemic pulmonary infiltration diagnosed by sputum Giemsa-staining].
Osaki M, Lee Y, Osamura Y, Ichiki T, Okabe M, Kawaguchi Y, Obiki M, Ito A, Goto M, Araie H, Goto T, Morishita T, Ozawa Y, Ito M, Miyamura K. Osaki M, et al. Among authors: morishita t. Rinsho Ketsueki. 2020;61(3):257-261. doi: 10.11406/rinketsu.61.257. Rinsho Ketsueki. 2020. PMID: 32224587 Japanese.
Targeted deep next generation sequencing identifies potential somatic and germline variants for predisposition to familial Burkitt lymphoma.
Okabe M, Morishita T, Yasuda T, Sakaguchi H, Sanada M, Kataoka K, Ogawa S, Shiraishi Y, Ichiki T, Kawaguchi Y, Ohbiki M, Matsumoto R, Osaki M, Goto T, Ozawa Y, Miyamura K. Okabe M, et al. Among authors: morishita t. Eur J Haematol. 2021 Jul;107(1):166-169. doi: 10.1111/ejh.13629. Epub 2021 Apr 12. Eur J Haematol. 2021. PMID: 33772882 No abstract available.
[Bacillus cereus bacteremia in patients with hematological disorders].
Nakashima M, Osaki M, Goto T, Kagaya Y, Kawashima N, Morishita T, Ozawa Y, Miyamura K. Nakashima M, et al. Among authors: morishita t. Rinsho Ketsueki. 2021;62(3):157-162. doi: 10.11406/rinketsu.62.157. Rinsho Ketsueki. 2021. PMID: 33828007 Japanese.
Comparison of Transplantation Outcomes after Foscarnet and Ganciclovir Administration as First-Line Anti-Cytomegalovirus Preemptive Therapy.
Miyao K, Terakura S, Ozawa Y, Sawa M, Kohno A, Kasahara S, Iida H, Ino K, Kusumoto S, Kasai M, Takami A, Kurahashi S, Kajiguchi T, Morishita T, Nishida T, Murata M; Nagoya Blood and Marrow Transplantation Group. Miyao K, et al. Among authors: morishita t. Transplant Cell Ther. 2021 Apr;27(4):342.e1-342.e10. doi: 10.1016/j.jtct.2020.12.012. Epub 2020 Dec 16. Transplant Cell Ther. 2021. PMID: 33836887 Free article.
872 results